Literature DB >> 28782123

The effects of storage of red blood cells on the development of postoperative infections after noncardiac surgery.

Savino Spadaro1, Fabio Silvio Taccone2, Alberto Fogagnolo1, Vito Fontana1, Riccardo Ragazzi1, Marco Verri1, Giorgia Valpiani3, Pantaleo Greco1, Margherita Bianconi1, Maurizio Govoni4, Roberto Reverberi4, Carlo Alberto Volta1.   

Abstract

BACKGROUND: Prolonged storage of red blood cells (RBCs) is a potential risk factor for postoperative infections. The objective of this study was to examine the effect of age of RBCs transfused on development of postoperative infection. STUDY DESIGN AND METHODS: In this prospective, double-blind randomized trial, 199 patients undergoing elective noncardiac surgery and requiring RBC transfusion were assigned to receive nonleukoreduced RBCs stored for not more than 14 days ("fresh blood" group, n = 101) or for more than 14 days ("old blood" group, n = 98). The primary outcome was occurrence of infection within 28 days after surgery; secondary outcomes were postoperative acute kidney injury (AKI), in-hospital and 90-day mortality, admission to intensive care unit, and hospital length of stay (LOS). As older blood was not always available, an "as-treated" (AT) analysis was also performed according to actual age of the RBCs transfused.
RESULTS: The median [interquartile range] storage time of RBCs was 6 [5-10] and 15 [11-20] days in fresh blood and in old blood groups, respectively. The occurrence of postoperative infection did not differ between groups (fresh blood 22% vs. old blood 25%; relative risk [RR], 1.17; confidence interval [CI], 0.71-1.93), although wound infections occurred more frequently in old blood (15% vs. 5%; RR, 3.09; CI, 1.17- 8.18). Patients receiving older units had a higher rate of AKI (24% vs. 6%; p < 0.001) and, according to AT analysis, longer LOS (mean difference, 3.6 days; CI, 0.6-7.5).
CONCLUSION: Prolonged RBC storage time did not increase the risk of postoperative infection. However, old blood transfusion increased wound infections rate and incidence of AKI.
© 2017 The Authors Transfusion published by Wiley Periodicals, Inc. on behalf of AABB.

Entities:  

Mesh:

Year:  2017        PMID: 28782123     DOI: 10.1111/trf.14249

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

Review 1.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

2.  Contrasting effects of stored allogeneic red blood cells and their supernatants on permeability and inflammatory responses in human pulmonary endothelial cells.

Authors:  Junghyun Kim; Trang T T Nguyen; Yue Li; Chen-Ou Zhang; Boyoung Cha; Yunbo Ke; Michael A Mazzeffi; Kenichi A Tanaka; Anna A Birukova; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-08       Impact factor: 5.464

3.  Erythrocyte Storage Lesion Improvements Mediated by Naringin Screened from Vegetable/Fruit Juice Using Cell Extract and HPLC-MS.

Authors:  Yuqi She; Qiong Liu; Xiyue Xiong; Ning Li; Jian Zhang
Journal:  J Anal Methods Chem       Date:  2022-04-26       Impact factor: 2.594

4.  Transfusion of red blood cells stored for shorter versus longer duration for all conditions.

Authors:  Akshay Shah; Susan J Brunskill; Michael Jr Desborough; Carolyn Doree; Marialena Trivella; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2018-12-22

5.  NLRP3 Inflammasome Activation Regulates Aged RBC Clearance.

Authors:  Li Qin; Zhao Fengyong; Zhang Jiamin; Yang Qixiu; Lu Geming; Xia Rongwei; Zhu Ziyan
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Using arterial-venous oxygen difference to guide red blood cell transfusion strategy.

Authors:  Alberto Fogagnolo; Fabio Silvio Taccone; Jean Louis Vincent; Giulia Benetto; Elaine Cavalcante; Elisabetta Marangoni; Riccardo Ragazzi; Jacques Creteur; Carlo Alberto Volta; Savino Spadaro
Journal:  Crit Care       Date:  2020-04-20       Impact factor: 19.334

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.